We are here to revolutionize interventional radiology, with a focus on transcatheter embolization— a vital technique for addressing hypervascular tumors and cutting off their blood supply.
Founded in Netherlands
NovaSeal® Launched
Bio-based Materials
Toxic Solvents
Revolutionary gel-based solutions for interventional radiology
In situ gels are specialized formulations that can be administered in a liquid form and transform into a gel, usually in response to physiological changes in temperature, etc. This remarkable feature allows for the controlled and sustained release of therapeutic/radiographic agents, ensuring that medications are delivered effectively to the targeted site.
Our flagship liquid embolic agent designed to revolutionize cancer treatment. NovaSeal stands at the intersection of innovation and compassion, engineered to provide targeted therapy that minimizes collateral damage to healthy tissues while maximizing therapeutic impact on tumors.
No complex preparation required
No anesthesia required
No heavy metals or toxic solvents
Explore our cutting-edge technology and revolutionary approach to cancer treatment.
Coming SoonUnderstand the science behind our gel-based technology and its impact on patient outcomes.
Coming SoonParticipate in our groundbreaking research and help advance cancer treatment technology.
Coming SoonNovaSeal® is designed to treat a range of conditions requiring precise blood vessel blockage
Targeted treatment for liver cancer with minimal damage to healthy tissue.
Effective embolization for kidney cancer treatment.
Precise treatment for hypervascular brain tumors.
Non-surgical treatment for uterine fibroids.
Minimally invasive treatment for prostate conditions.